Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 12/19/2025 | PUT | $70.00 | 1,053 | +715 | +211.54% |
| 01/16/2026 | PUT | $65.00 | 986 | +142 | +16.82% |
| 11/21/2025 | PUT | $70.00 | 1,141 | +108 | +10.45% |
| 01/16/2026 | PUT | $60.00 | 1,163 | +95 | +8.90% |
| 01/16/2026 | PUT | $48.00 | 117 | +6 | +5.41% |
| 01/21/2028 | PUT | $65.00 | 81 | +5 | +6.58% |
| 01/21/2028 | PUT | $100.00 | 0 | 0 | |
| 01/21/2028 | PUT | $105.00 | 0 | 0 | |
| 12/19/2025 | CALL | $35.00 | 99 | -1 | -1.00% |
| 01/16/2026 | CALL | $47.00 | 13 | -1 | -7.14% |
| 11/21/2025 | CALL | $60.00 | 1,703 | -1 | -0.06% |
| 11/21/2025 | CALL | $70.00 | 976 | -22 | -2.20% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Price (T.Rowe) New Horizons Fund | 4.75% | 3.36M | 37.7M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.88% | 2.04M | 22.91M |
| Vanguard Total Stock Market Index Fund | 2.85% | 2.01M | 22.6M |
| Price (T.Rowe) Health Sciences Fund | 2.49% | 1.76M | 19.77M |
| Federated Hermes Kaufmann Fund | 1.72% | 1.22M | 13.64M |
| iShares Russell 2000 ETF | 1.66% | 1.18M | 13.22M |
| Fidelity Growth Company Fund | 1.66% | 1.17M | 13.15M |
| Federated Hermes Kaufmann Small Cap Fund | 1.57% | 1.11M | 12.47M |
| Vanguard Extended Market Index Fund | 1.27% | 899.79k | 10.1M |
| Artisan International Small-Mid Fund | 1.15% | 811.71k | 9.11M |
Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts
11/20 01:43 pm
Benzinga
Read moreNovartis Maintains Outlook Even As Generics Bite Into Profits
10/28 06:58 am
Benzinga
Read moreWhy Dyne Therapeutics Stock Crushed the Market on Monday
10/27 06:17 pm
The Motley Fool
Read moreStock Market Today: Dow Jones, S&P 500 Futures Climb Ahead Of Busy Week On Wall Street—Novartis, Nucor, Waste Management In Focus
10/27 06:02 am
Benzinga
Read moreNovartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline
10/26 01:00 pm
GlobeNewswire Inc.
Read moreTop Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
07/01 01:38 pm
Benzinga
Read moreAvidity (RNA) Up 33% on Rare Muscle Disease Study Results
06/13 10:39 am
Zacks Investment Research
Read moreA Glimpse Into The Expert Outlook On Avidity Biosciences Through 6 Analysts
06/10 08:01 am
Benzinga
Read more2 Potentially High-Reward Growth Stocks to Buy Right Now
05/29 08:45 am
The Motley Fool
Read moreCoherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
05/09 05:15 pm
Zacks Investment Research
Read moreAbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
05/07 06:05 pm
Zacks Investment Research
Read moreTo The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
04/18 02:29 pm
Benzinga
Read moreWhere Avidity Biosciences Stands With Analysts
04/11 08:00 am
Benzinga
Read moreNeuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
03/14 03:29 pm
Benzinga
Read moreAmerican Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
03/05 10:30 am
Benzinga
Read moreA Closer Look at 5 Analyst Recommendations For Avidity Biosciences
03/05 08:00 am
Benzinga
Read moreTesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
03/04 11:40 am
Benzinga
Read moreHormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
02/29 12:30 pm
Benzinga
Read moreTop 3 Health Care Stocks You May Want To Dump In Q1
02/29 11:40 am
Benzinga
Read moreTech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
02/29 10:20 am
Benzinga
Read moreAvidity Biosciences, Inc. (RNA) Reports Q4 Loss, Misses Revenue Estimates
02/28 06:20 pm
Zacks Investment Research
Read moreStrength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength?
02/07 05:13 am
Zacks Investment Research
Read moreStrength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?
01/29 09:54 am
Zacks Investment Research
Read moreThe Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks
01/06 06:58 am
MarketWatch
Read moreBristol Myers (BMY) Partners With SystImmune for Oncology Drug
12/12 12:04 pm
Zacks Investment Research
Read moreWill Bristol Myers' (BMY) Efforts to Boost Portfolio be Enough?
12/08 01:21 pm
Zacks Investment Research
Read moreThe Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie
12/01 06:09 am
Zacks Investment Research
Read moreBiotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More
11/30 11:33 am
Zacks Investment Research
Read moreCompany News for Nov 29, 2023
11/29 10:35 am
Zacks Investment Research
Read moreDow refreshes highest close in nearly four months after Fed official’s remarks, with inflation data ahead
11/28 05:56 pm
MarketWatch
Read morePDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On Tuesday
11/28 10:39 am
Benzinga
Read moreUS Stocks Mixed; House Prices Rise In September
11/28 10:33 am
Benzinga
Read moreAvidity’s stock rockets on Bristol Myers deal that could mean $2.2 billion in milestone payments
11/28 09:33 am
MarketWatch
Read moreWhere Avidity Biosciences Stands With Analysts
08/09 08:00 am
Benzinga
Read moreAvidity Biosciences, Inc. (RNA) Reports Q2 Loss, Tops Revenue Estimates
08/08 07:15 pm
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
05/22 11:00 am
Benzinga
Read moreWhat 10 Analyst Ratings Have To Say About Avidity Biosciences
05/17 05:00 pm
Benzinga
Read moreAvidity Biosciences, Inc. (RNA) Reports Q1 Loss, Tops Revenue Estimates
05/09 06:15 pm
Zacks Investment Research
Read moreUS Stocks Mixed; Amazon Posts Upbeat Results
04/28 10:07 am
Benzinga
Read moreAfter Falling 18% in 1 Day, Is This Growth Stock Done For?
04/11 11:23 am
The Motley Fool
Read moreThe Zacks Analyst Blog Highlights bluebird, Oncternal Therapeutics, Avidity, Ascendis and Vertex Pharmaceuticals
04/06 05:37 am
Zacks Investment Research
Read more